Therapeutic Asset Ratings

175 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Ivonescimab Lung Cancer	SWOG Cancer Research Network	P2	CCC (53)
Jcar017 (Lisocabtagene Maraleucel) Transformed Follic Lymph to Diff Large B-Cell Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Monalizumab Small Cell Lung Carcinoma	SWOG Cancer Research Network	P2	CCC (53)
Mosunetuzumab Nodal Marginal Zone B-Cell Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Mosunetuzumab Splenic Marginal Zone Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Mosunetuzumab Transformed Follic Lymph to Diff Large B-Cell Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Polatuzumab Vedotin Nodal Marginal Zone B-Cell Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Polatuzumab Vedotin Splenic Marginal Zone Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Polatuzumab Vedotin Transformed Follic Lymph to Diff Large B-Cell Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Selpercatinib Lung Cancer	SWOG Cancer Research Network	P2	CCC (53)
Sotorasib Lung Adenocarcinoma	SWOG Cancer Research Network	P2	CCC (53)
Tafasitamab High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	SWOG Cancer Research Network	P2	CCC (53)
Tazemetostat High Grade B-Cell Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Tazemetostat High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	SWOG Cancer Research Network	P2	CCC (53)
Tepotinib Lung Cancer	SWOG Cancer Research Network	P2	CCC (53)
Tisagenlecleucel Transformed Follic Lymph to Diff Large B-Cell Lymphoma	SWOG Cancer Research Network	P2	CCC (53)
Capmatinib Lung Cancer	SWOG Cancer Research Network	P2	CCC (52)
Blinatumomab Acute Leukemia	SWOG Cancer Research Network	P2	CCC (51)
Blinatumomab Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	CCC (51)
Revumenib B-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P2	CCC (51)
Revumenib T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P2	CCC (51)
OBI 3424 T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P1/2	CCC (48)
OBI 3424 Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia	SWOG Cancer Research Network	P1/2	CCC (48)
OBI 3424 T-Lymphoblastic Lymphoma	SWOG Cancer Research Network	P1/2	CCC (48)
egf816 Lung Cancer	SWOG Cancer Research Network	P2	CC (46)

Showing 151 to 175 of 175 assets

PreviousPage 7 of 7Next